Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis

E Pathan, S Abraham, E Van Rossen… - Annals of the …, 2013 - ard.bmj.com
Objectives To evaluate the efficacy and safety of an oral phosphodiesterase 4 inhibitor,
apremilast, in treatment of ankylosing spondylitis (AS) by monitoring symptoms and signs in …